Kratom withdrawal is the set of physical and psychological symptoms that follow when a person reduces or stops regular use of kratom. Here at Foundry Front Range, we understand that stopping kratom after months or years of regular use can feel intimidating, and that not knowing what to expect is part of what keeps people stuck.
This article explains what kratom withdrawal looks like, how the timeline typically unfolds, and which treatment options match different levels of severity. We cover it from a clinical lens because dose, product type, and co-use of other substances all change the picture.
Our medically supervised detox program is not always necessary, but it is sometimes the safest starting point. If you are reading this on behalf of someone you love, the same information applies.
Key Takeaways
- Withdrawal usually starts within 12 to 24 hours and peaks around days 2 to 4. Most physical symptoms resolve within one week, though psychological symptoms can linger into a post-acute phase that lasts weeks to months.
- There is no FDA-approved medication specifically for kratom withdrawal. Clinicians use targeted symptom-management drugs (clonidine, antiemetics, NSAIDs) and, in opioid-overlap cases, evidence-based medications like buprenorphine under supervision.
- Concentrated 7-hydroxymitragynine (7-OH) products are now the main severity driver. These newer extract products produce a harder, more opioid-like withdrawal than traditional leaf or powder, and many people do not realize what they have been using.
- Medically supervised detox is appropriate when symptoms destabilize vitals, when other substances are involved, or when psychiatric risk is high. For lower-severity cases, outpatient support with structured follow-up is often enough.
What Kratom Withdrawal Is and How Clinicians Diagnose Dependence
Kratom (Mitragyna speciosa) is a plant whose leaves contain compounds that act on opioid and other neural receptors. Regular use can produce physical dependence. When use stops, withdrawal follows.
Severity depends on several variables, including:
- Total daily dose
- Duration of use
- Product potency and form (leaf, powder, extract, 7-OH concentrate)
- Whether other substances are involved
- Underlying mental health conditions
Many people are surprised that a plant-based product can produce a withdrawal syndrome at all. The clinical evidence on dependence is now well established.
A clinical diagnosis of kratom dependence rests on documented patterns of repeated use, observable functional impairment, and reproducible withdrawal when use stops. Physiological dependence and substance use disorder are not the same thing. You can develop physical dependence without meeting full criteria for a substance use disorder.
How the Alkaloids Work
Kratom’s primary alkaloids are mitragynine and 7-hydroxymitragynine. Both bind opioid receptors and affect other neural systems, producing pain relief and opioid-like effects at higher doses.
A 2022 pharmacology review in the National Library of Medicine outlines these mechanisms in detail and connects them to the dependence risk clinicians see in practice.
What Clinicians Document
Effective assessment requires more than asking whether someone “uses kratom.” Clinicians document specifics that shape treatment planning:
- Estimated grams per day and typical preparation
- Frequency of use and duration
- Product type (powder, capsule, extract, concentrate)
- Vendor or brand, when known
- Functional impairment from use
- Reproducible withdrawal on prior attempts to stop
- Concurrent substances, including prescriptions
Standard urine drug screens do not detect kratom alkaloids. The clinical picture relies on patient history rather than testing.
This combination of dependence patterns, no routine testing, and unregulated product variability is why supervised assessment matters. It also shapes the right level of care, including whether the whole-person treatment philosophy we use for substance use and co-occurring conditions is the right fit.
Common Symptoms of Kratom Withdrawal
Kratom withdrawal produces both physical and psychological symptoms. The physical symptoms tend to be acute in the first three to seven days. The psychological symptoms often outlast the physical phase and drive most of the relapse risk in early recovery.
Common physical symptoms include:
- Nausea, vomiting, and diarrhea
- Muscle aches and joint pain
- Sweating, runny nose, and watery eyes
- Tremors and a faster than usual heart rate
- Loss of appetite and abdominal cramping
- Restless legs and disturbed sleep
Common psychological symptoms include:
- Anxiety and panic
- Irritability and low mood
- Strong cravings for kratom
- Insomnia and fragmented sleep
- Difficulty concentrating
The physical symptoms raise the risk of dehydration and electrolyte loss when nausea and diarrhea overlap. The psychological symptoms raise relapse and safety concerns, particularly when anxiety or low mood become severe.
If you cannot keep fluids down or experience suicidal thoughts, get emergency medical care immediately. Call or text 988 for the Suicide and Crisis Lifeline.
Kratom Withdrawal Timeline: Day by Day
Kratom withdrawal follows a recognizable clinical timeline. Symptoms typically begin within 12 to 24 hours of the last dose. Acute symptoms peak between days 2 and 4, and most physical symptoms resolve within one week.
A subset of psychological symptoms can persist into a post-acute withdrawal syndrome (PAWS) lasting weeks to months. The table below summarizes what most people experience, based on patterns reported across published case series and clinical reviews.
| Phase | Time After Last Dose | Common Symptoms | What to Watch For |
| Onset | 6 to 24 hours | Anxiety, restlessness, runny nose, mild GI upset, sweating | Early sign of dependence severity |
| Acute peak | Days 2 to 4 (48 to 96 hours) | Nausea, vomiting, diarrhea, muscle aches, insomnia, strong cravings, irritability | Highest risk of dehydration and crisis |
| Late acute | Days 5 to 7 | Improving GI symptoms, lingering fatigue, continued anxiety and sleep disruption | Risk shifts from medical to psychological |
| Sub-acute | Weeks 2 to 4 | Mood swings, ongoing insomnia, residual cravings, low energy | Relapse risk window peaks |
| PAWS (protracted) | Weeks to months | Intermittent anxiety, depressed mood, sleep disruption, cravings | Suggests need for ongoing mental health care |
Higher daily intake, longer duration of use, concentrated 7-OH products, and co-use of opioids or benzodiazepines all extend this timeline.
Tapering instead of stopping abruptly compresses symptom severity but may extend total duration. For people with significant dependence, medically supervised detox usually offers the safer pathway.
How Kratom Withdrawal Compares With Opioid Withdrawal
Kratom withdrawal is usually milder and shorter than withdrawal from full opioid agonists like heroin or fentanyl. The line is blurring as concentrated kratom extracts become more common.
A 2020 systematic review summarized human case series, surveys, and animal data. It found that kratom has opioid receptor activity and clear dependence potential, while typically producing fewer severe autonomic signs than full opioid withdrawal.
This is the practical comparison most clinicians use to decide between outpatient management and medically supervised inpatient care:
| Feature | Kratom Withdrawal | Full Opioid Withdrawal |
| Onset | 12 to 24 hours after last dose | 6 to 12 hours (short-acting) or 24 to 48 hours (long-acting) |
| Peak severity | Days 2 to 4 | Days 1 to 3 |
| Acute duration | Most resolve in 5 to 7 days | 5 to 10 days typically |
| Autonomic signs | Sweating, tachycardia, mild blood pressure changes | Severe sweating, tachycardia, high blood pressure, dilated pupils |
| Pain symptoms | Muscle and joint aches, manageable | Severe bone and muscle pain, often requires medication |
| Cravings | Significant but usually less intense | Intense, high relapse risk |
| GI symptoms | Nausea, vomiting, diarrhea | Severe GI distress |
| Medical risk | Lower in most cases; rises with co-use or concentrates | Higher, often requires medical detox |
| Typical care level | Outpatient or ASAM 3.7 depending on severity | Often requires ASAM 3.7 |
For people using concentrated 7-OH extract products, the kratom column starts to look more like the opioid column. That is the most important shift in this space over the past two years.
7-Hydroxymitragynine Concentrates: The Most Important Kratom Withdrawal Shift in 2024 to 2026
The biggest change in kratom withdrawal severity right now is not happening at the leaf level. It is happening with concentrated extract products that isolate 7-hydroxymitragynine (7-OH), the more potent of kratom’s two main alkaloids.
These products have become widely available at gas stations, smoke shops, and online over the past two years. The clinical picture they produce is meaningfully different from traditional kratom powder.
Why 7-OH Matters Pharmacologically
In raw kratom leaf, 7-OH is present in trace amounts, typically less than 2% of total alkaloid content. Mitragynine, the dominant alkaloid in the leaf, is a partial mu-opioid receptor agonist with relatively modest opioid effects.
7-OH, by contrast, is a much more efficacious mu-opioid agonist. It is estimated to be substantially more potent than morphine at that receptor.
Concentrated 7-OH products on the market now contain 7-OH at percentages many times higher than the natural ratio. A user consuming a single 7-OH tablet or shot may receive a dose of opioid-active alkaloid that would require many grams of traditional leaf. The pharmacology has shifted from a partial opioid effect to a full opioid effect.
What This Means for Withdrawal
People who have been using concentrated 7-OH products regularly often present with a withdrawal pattern that looks much closer to short-acting opioid withdrawal than to the traditional kratom withdrawal described in older case series. That pattern includes:
- Faster onset, sometimes within 6 to 12 hours of the last dose
- More intense autonomic symptoms (sweating, tachycardia, blood pressure changes)
- Severe muscle and joint pain rather than the mild aches typical of leaf withdrawal
- Stronger cravings and higher early relapse risk
- More frequent need for medications like buprenorphine, which is also used for Suboxone withdrawal and traditional opioid use disorder
Many people using 7-OH products do not realize they are using a different substance than the kratom tea or capsules they may have started with. The label still says kratom. The clinical reality is closer to opioids.
Practical Assessment Questions
When evaluating someone for kratom withdrawal in 2026, clinicians need to ask product-specific questions, not just total daily grams:
- Is the product traditional powder or capsule, or is it an extract, shot, or tablet?
- Does the label mention 7-OH, 7-hydroxy, or 7-hydroxymitragynine?
- What is the listed alkaloid concentration if available?
- Where was it purchased (smoke shop, gas station, online vendor)?
- Have prior attempts to stop produced a withdrawal that felt like opioid withdrawal?
If the answer points to a concentrated 7-OH product, the right starting point is more often medically supervised detox than outpatient support.
What Influences Severity and Duration
Kratom withdrawal severity varies significantly between people. People who have used kratom heavily for more than a year, or who have been using concentrated extracts, generally need more intensive support.
The factors that most consistently predict a harder withdrawal include:
- Total daily grams (or 7-OH milligrams) consumed
- Duration of use
- Product potency, especially concentrated 7-OH extracts
- Concurrent use of opioids or benzodiazepines
- Untreated mental health conditions
- Prior failed attempts to stop
Co-use of benzodiazepines is a separate red flag. Stopping benzodiazepines abruptly can be medically serious on its own. The combination changes the clinical risk profile substantially.
If kratom and benzodiazepines are both in use, Valium and other benzodiazepine dependence needs its own supervised plan rather than being lumped into a single detox attempt.
Polysubstance use involving opioids, including fentanyl, raises the immediate medical risk further. The risk of fentanyl overdose after even a short period of reduced use is a real concern, particularly for people who have been using kratom to self-manage prior opioid use.
Tolerance loss is rapid. The illicit opioid supply in Colorado remains dangerous.
Treatment Options for Kratom Withdrawal
Kratom withdrawal treatment follows a stepped approach: symptom stabilization first, then ongoing care to address underlying patterns. The right starting point depends on severity, co-occurring conditions, and what supports are available at home.
Outpatient Supportive Care
For mild to moderate kratom withdrawal in someone without significant co-use or psychiatric risk, outpatient care can work well. The core components include:
- Hydration and electrolyte replacement
- Consistent sleep routines
- Balanced meals to support recovery
- Regular check-ins with a clinician
- Clear escalation criteria if symptoms worsen
- Brief psychosocial counseling or CBT
Many people benefit from a structured program like our intensive outpatient program (IOP), which provides clinical support without requiring time away from home. For people who cannot attend in person, our virtual intensive outpatient program provides the same evidence-based care via telehealth.
Symptom-Targeted Medications
There is no FDA-approved medication specifically for kratom withdrawal. Clinicians use targeted, non-opioid medications to manage the most disruptive symptoms:
- Clonidine or lofexidine: For autonomic symptoms like sweating, tachycardia, and agitation
- Antiemetics (ondansetron, metoclopramide): For nausea and vomiting
- Loperamide: For diarrhea, with attention to dose and cardiac risk
- NSAIDs: For muscle aches and joint pain
- Trazodone or low-dose mirtazapine: For sleep and appetite, when appropriate
Medication choices depend on medical history, drug interactions, and QT considerations. Benzodiazepines are generally avoided because they create their own dependence risk and respiratory concerns.
Medication-Assisted Treatment for Opioid Overlap
For people whose kratom use has crossed into opioid-like dependence, especially with concentrated 7-OH products, opioid agonist medications like buprenorphine can be highly effective. These medications support both withdrawal management and longer-term stabilization, and they must be prescribed by experienced clinicians in a structured medical setting.
Medically Supervised Detox (ASAM 3.7)
Medically supervised inpatient detox is the right starting point in several specific situations:
- Withdrawal symptoms destabilize vital signs
- Severe vomiting or dehydration threatens fluid and electrolyte balance
- Significant psychiatric risk, including suicidal ideation
- Polysubstance use creates overlapping withdrawal patterns
- Concentrated 7-OH product use with heavy daily dosing
- A prior failed outpatient attempt at stopping
Our detox program provides 24/7 nursing and medical oversight, medication management, and a direct pathway into residential addiction treatment when ongoing care is appropriate. We accept most insurance plans and Health First Colorado, and our admissions team verifies coverage before admission.
When to Seek Emergency or Inpatient Care
Most people going through kratom withdrawal do not need emergency care. A meaningful minority do.
Get emergency care immediately for any of the following:
- Persistent vomiting that prevents you from keeping fluids down
- Fainting, chest pain, very rapid heart rate, or very high blood pressure
- Active suicidal thoughts or intent (call or text 988, or go to the nearest emergency department)
- Severe agitation, hallucinations, or any signs of psychosis
- Seizures, especially if benzodiazepines or alcohol are also being stopped
Consider medically supervised inpatient detox if you have any of the following:
- Daily use of concentrated 7-OH products
- Heavy daily kratom use sustained for more than several months
- Co-use of opioids, benzodiazepines, or alcohol
- Significant mental health conditions including major depression, anxiety, or trauma
- A prior failed outpatient attempt at stopping
- Pregnancy (neonatal withdrawal risk and obstetric considerations)
For families researching options for a loved one, our family addiction program is part of the care model from admission forward. Family involvement consistently improves outcomes, particularly for adults whose home environment will shape the early recovery phase.
Can Kratom Be Used to Self-Manage Opioid Withdrawal?
Some people use kratom to blunt opioid withdrawal symptoms. A portion of online survey data describes this self-treatment pattern.
The clinical evidence is mixed. Kratom can reduce short-term opioid withdrawal severity for some people. The substitution often produces its own dependence, the product is unregulated, and outcomes vary widely between users.
For opioid use disorder specifically, the evidence-based approach is medication-assisted treatment with buprenorphine or methadone under clinical supervision. These medications have decades of safety and outcome data behind them.
Self-treatment with kratom, particularly with the current 7-OH extract products, often replaces one opioid-like dependence with another. Sometimes a more severe one.
If you are using kratom this way and want to stop both, integrated treatment that addresses opioid use disorder and kratom dependence at the same time is the right path. That treatment exists, and it is covered by most insurance plans, including Medicaid.
Post-Acute Withdrawal and Aftercare
Most physical kratom withdrawal symptoms resolve within one to two weeks. Some psychological symptoms can persist longer in a smaller subset of people.
This is sometimes called post-acute withdrawal syndrome, or PAWS. Symptoms can include anxiety, low mood, insomnia, and intermittent cravings.
It is not a sign of treatment failure. PAWS is a recognized clinical pattern that responds to ongoing care.
PAWS responds well to a combination of consistent sleep hygiene, regular movement, cognitive behavioral techniques for craving and mood, peer support, and short-term medication when a clinician recommends it.
The risk pattern most worth watching is an early relapse triggered by lingering anxiety or insomnia that the person decides to manage by returning to kratom. The clinical understanding of what relapse means in addiction recovery is that it is a medical event, not a moral failure.
It usually signals a need to step back into structured care rather than start over.
Refer to specialty mental health care if there is suicidal ideation, psychosis, severe functional decline, or symptoms continuing past eight to twelve weeks without improvement. Our approach to co-occurring mental health treatment addresses both the substance use and the underlying mental health pattern.
Building structured support before discharge from detox is the most reliable way to prevent early relapse. Treating one without the other often produces recovery that does not last.
Talk With Our Admissions Team About Kratom Detox
Reading about kratom withdrawal is one thing. Knowing whether your situation calls for outpatient support, medically supervised detox, or a step into residential treatment is another. That decision is easier with a clinical conversation than alone at a screen.
Our admissions team can walk you through what care would look like, verify your insurance benefits including Medicaid, and answer the questions you came here trying to answer. The conversation is confidential, there is no obligation, and there is no pressure to commit to anything you are not ready for.
Whether you are asking for yourself or for someone you love, you can take the next step in two ways:
- Call 720-807-7867 to speak with an admissions specialist now
- Use our insurance verification form to start without a phone call
Frequently Asked Questions About Kratom Withdrawal
How soon after stopping kratom will I feel withdrawal symptoms?
Most people feel the first symptoms within 12 to 24 hours after their last dose. Early symptoms are typically restlessness, anxiety, runny nose, and mild GI upset. Concentrated 7-OH extract users may notice symptoms within 6 to 12 hours, which is closer to short-acting opioid withdrawal.
How long does kratom withdrawal last?
Acute physical symptoms peak between days 2 and 4 and most resolve within 5 to 7 days. A subset of people experience post-acute withdrawal syndrome (PAWS) with psychological symptoms that can last several weeks to months.
Is kratom withdrawal dangerous?
Most kratom withdrawal cases are uncomfortable but not life-threatening. Medical risk rises with severe dehydration from vomiting, suicidal ideation, co-use of opioids or benzodiazepines, untreated mental health conditions, or pregnancy. Seek emergency care if any of those apply.
Should I taper kratom or quit cold turkey?
Tapering usually produces milder symptoms and is the recommended approach for people with significant daily use, long duration of use, or concentrated 7-OH product use. Cold turkey is more tolerable for shorter, lower-dose users but carries higher symptom severity. A clinician can help you build a taper that matches your situation.
What medications help with kratom withdrawal?
No medication is FDA-approved specifically for kratom withdrawal. Clinicians commonly use clonidine or lofexidine for autonomic symptoms, antiemetics for nausea, loperamide for diarrhea, NSAIDs for muscle aches, and short-term sleep aids when needed. For opioid-overlap cases, buprenorphine is sometimes used under medical supervision.
When should I go to inpatient detox for kratom?
Consider medically supervised detox when you have severe vomiting or dehydration, unstable vital signs, significant psychiatric risk, daily use of concentrated 7-OH products, sustained heavy daily use, co-use of opioids or benzodiazepines, or a prior failed outpatient attempt at stopping.
Can I use kratom to come off opioids?
Some people do, and survey data describes this pattern. Kratom is unregulated, often produces its own dependence, and can complicate later treatment.
Evidence-based medications like buprenorphine and methadone are the recommended approach for opioid use disorder. Integrated treatment is available and is covered by most insurance plans.
Does insurance or Medicaid cover kratom detox?
Most insurance plans, including Health First Colorado (Medicaid), cover medically supervised detox and residential addiction treatment for kratom dependence when clinically indicated. Our admissions team can verify your specific coverage before you commit to anything.
Get Help With Kratom Withdrawal at Foundry Front Range
Kratom withdrawal is a real clinical condition. The right care depends on dose, product type, co-use, and mental health context.
Our medically supervised detox program (ASAM 3.7) and integrated residential addiction treatment (ASAM 3.5) are designed to meet you where you are, whether you have been using traditional kratom for years or recently switched to a concentrated 7-OH extract product.
We accept most major insurance plans and Health First Colorado. Our admissions team conducts a confidential clinical assessment, walks you through what care would look like, and verifies your benefits before you arrive.
Call 720-807-7867 to speak with our admissions team, orstart the admissions process online.
